Medtronic wins CE mark for ApexCut surgical blades
April 24, 2026
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its ApexCut surgical blades for ENT procedures.
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its ApexCut surgical blades for ENT procedures.
A new fiber probe developed by researchers at The University of Texas at Austin delivers two major innovations in health monitoring to help both patients around the world and the clinicians who care for them.
A freeze-dried blood product that could be stored for years on ambulances or in remote emergency departments is showing promise at treating traumatic brain injuries.
A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely prevented or cured type 1 diabetes in mice in a study by Stanford Medicine researchers.
Approved Thursday via the FDA’s Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for hearing loss—and the first treatment to target an underlying cause of the condition.
Ultra-efficient chip design enables extremely strong cryptography algorithms to run on energy-constrained edge devices.
Biotronik announced today that it received FDA approval for its Acticor Sky and Rivacor implantable defibrillator systems.
An international team of researchers has identified an East African bat coronavirus capable of entering human cells.
Functioning as a smart dimmer, it can selectively adjust the brightness of every pixel during laser scanning, and prevent unintended neural activation, thereby significantly enhancing the precision of all-optical brain manipulation and imaging.
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages.